IDENTIFICATION OF PATIENTS WITH POOR PROGNOSIS STAGE-II BREAST-CANCER

被引:0
|
作者
OREILLY, SM
CAMPLEJOHN, RS
HOWELL, A
RUBENS, RD
RICHARDS, MA
机构
[1] GUYS & ST THOMAS HOSP,RICHARD DIMBLEBY DEPT CANC RES,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1,ENGLAND
[2] CHRISTIE HOSP & HOLT RADIUM INST,MANCHESTER M20 9BX,LANCS,ENGLAND
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:449 / 449
页数:1
相关论文
共 50 条
  • [1] STAGE-II BREAST-CANCER
    不详
    [J]. AMERICAN JOURNAL OF NURSING, 1982, 82 (02) : 271 - &
  • [2] THE USE OF FLOW-CYTOMETRY FOR THE PROGNOSIS OF STAGE-II ADJUVANT TREATED BREAST-CANCER PATIENTS
    KUTE, TE
    MUSS, HB
    COOPER, MR
    CASE, LD
    BUSS, D
    STANLEY, V
    GREGORY, B
    GALLESHAW, J
    BOOHER, K
    [J]. CANCER, 1990, 66 (08) : 1810 - 1816
  • [3] THROMBOEMBOLIC RISK OF TAMOXIFEN IN PATIENTS WITH STAGE-II BREAST-CANCER
    LEVINE, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1579 - 1579
  • [4] MULTIMODAL THERAPY FOR STAGE-II BREAST-CANCER
    FORBES, JF
    [J]. LANCET, 1977, 2 (8047): : 1079 - 1079
  • [5] ADJUVANT CHEMOTHERAPY IN STAGE-II BREAST-CANCER
    RIVKIN, S
    GLUCKSBERG, H
    RASMUSSEN, S
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 353 - 353
  • [6] MULTIMODAL THERAPY FOR STAGE-II BREAST-CANCER
    SMITH, IE
    POWLES, TJ
    [J]. LANCET, 1978, 2 (8103): : 1313 - 1313
  • [7] ADJUVANT THERAPY OF STAGE-II BREAST-CANCER
    CARBONE, PP
    [J]. CANCER, 1990, 65 (09) : 2148 - 2154
  • [8] MULTIMODAL THERAPY FOR STAGE-II BREAST-CANCER
    EDELSTYN, GA
    BATES, T
    KITCHEN, G
    NICOL, NT
    BRINKLEY, D
    MACRAE, KD
    SPITTLE, M
    WHEELER, T
    [J]. LANCET, 1978, 2 (8099): : 1092 - 1092
  • [9] MULTIMODAL THERAPY FOR STAGE-II BREAST-CANCER
    LEAPER, DJ
    LEIBERMAN, DP
    MACINTYRE, J
    [J]. LANCET, 1977, 2 (8039): : 660 - 661
  • [10] STEROID-RECEPTORS AND PROGNOSIS IN OPERABLE (STAGE-I AND STAGE-II) BREAST-CANCER
    STEWART, JF
    RUBENS, RD
    MILLIS, RR
    KING, RJB
    HAYWARD, JL
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (10): : 1381 - 1387